M A Lebot - JoVE Visualize

Showing results (1-10 of 2) with videos related to

Pageof 1

Sort By:

Therapie|September 1, 1989

[Adjusting the dosage of netilmicin from two measurements. Program validation]Y Guedes, J F Abgrall, M A Lebot, et al.

Oncologie (Paris, France)|July 21, 2015

Evaluation in usual practice of the bevacizumab-FOLFIRI combination for the first-line treatment of patients with unresectable metastatic colorectal cancer treated in 2006: focus on resected patients and oncogeriatrics: AVASTIN OUEST cohort of the Observatory of Cancer of the Brittany and Pays de la Loire Areas (Observatoire dédié au Cancer Bretagne / Pays de la Loire)J P Metges, M A Lebot, R Faroux, et al.

Pageof 1

Showing results (1-10 of 2) with videos related to

Sort By:

Pageof 1

Therapie|September 1, 1989

[Adjusting the dosage of netilmicin from two measurements. Program validation]Y Guedes, J F Abgrall, M A Lebot, et al.

Oncologie (Paris, France)|July 21, 2015

Evaluation in usual practice of the bevacizumab-FOLFIRI combination for the first-line treatment of patients with unresectable metastatic colorectal cancer treated in 2006: focus on resected patients and oncogeriatrics: AVASTIN OUEST cohort of the Observatory of Cancer of the Brittany and Pays de la Loire Areas (Observatoire dédié au Cancer Bretagne / Pays de la Loire)J P Metges, M A Lebot, R Faroux, et al.

Pageof 1